E6AP in the brain: One protein, dual function, multiple diseases

Molecular Neurobiology

Volumn 49, Issue 2, 2014, Pages 827-839

  El Hokayem, Jimmy ^a   Nawaz, Zafar ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Aging; Angelman syndrome; Autism; Brain; E6AP; Nuclear hormone receptors; Transcriptional coactivator; UBE3A; Ubiquitin ligase

Indexed keywords

ANDROGEN RECEPTOR; E6 ASSOCIATED PROTEIN; ESTROGEN RECEPTOR; MINICHROMOSOME MAINTENANCE PROTEIN 7; MYC PROTEIN; PROGESTERONE RECEPTOR; PROTEIN E6; PROTEIN MDM2; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; PROTEIN BINDING; UBE3A PROTEIN, HUMAN;

ALPHA HELIX; ANTERIOR COMMISSURE; ANTERIOR HYPOTHALAMUS; ATAXIA; AUDIOGENIC SEIZURE; AUTISM; BASAL GANGLION; BRAIN; BRAIN CORTEX; BRANCHIAL ARCH; CARBOXY TERMINAL SEQUENCE; CELL CYCLE PROGRESSION; CEREBELLUM; CHROMOSOME 15Q; CHROMOSOME 7; CRYSTAL STRUCTURE; DNA REPAIR; ENZYME ACTIVE SITE; EXON; GENE; GENE EXPRESSION; HAPPY PUPPET SYNDROME; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HUMAN; HUNTINGTON CHOREA; HYPOPHYSIS; LONG TERM POTENTIATION; MITRAL CELL; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NONHUMAN; NOSE MUCOSA; OLFACTORY BULB; OPTIC CHIASM; PARKINSON DISEASE; POSTERIOR HYPOTHALAMUS; PRADER WILLI SYNDROME; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PURKINJE CELL; RETT SYNDROME; REVIEW; TECTUM; TEGMENTUM; THALAMUS; TONGUE; UBE3A GENE; UBIQUITINATION; WART VIRUS; ANIMAL; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANGELMAN SYNDROME; ANIMALS; BRAIN; CHILD DEVELOPMENT DISORDERS, PERVASIVE; HUMANS; NERVOUS SYSTEM DISEASES; PROTEIN BINDING; RETT SYNDROME; UBIQUITIN-PROTEIN LIGASES;

EID: 84896505115     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8563-y     Document Type: Review

References (117)

1. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75(3):495-505 (Pubitemid 23335075)
2. Glickman MH, Ciechanover A (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82(2):373-428 (Pubitemid 34654457)
3. Nawaz Z, O'Malley BW (2004) Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription? Mol Endocrinol 18(3):493-499 (Pubitemid 38328197)
4. Etlinger JD, Goldberg AL (1977) A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes. Proc Natl Acad Sci U S A 74(1):54-58 (Pubitemid 8025869)
5. Ciehanover A, Hod Y, Hershko A (1978) A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. Biochem Biophys Res Commun 81(4):1100-1105 (Pubitemid 8331462)
6. Hershko A, Heller H, Elias S, Ciechanover A (1983) Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. J Biol Chem 258(13):8206-8214
7. Fang S,Weissman AM (2004) A field guide to ubiquitylation. Cell Mol Life Sci 61(13):1546-1561 (Pubitemid 38962038)
8. Powell SR (2006) The ubiquitin-proteasome system in cardiac physiology and pathology. Am J Physiol Heart Circ Physiol 291(1):H1-H19
9. Meiners S, Ludwig A, Stangl V, Stangl K (2008) Proteasome inhibitors: poisons and remedies. Med Res Rev 28(2):309-327 (Pubitemid 351281191)
10. Tomaic V, Pim D, Banks L (2009) The stability of the human papillomavirus E6 oncoprotein is E6AP dependent. Virology 393(1):7-10
11. Yamamoto Y, Huibregtse JM, Howley PM (1997) The human E6- AP gene (UBE3A) encodes three potential protein isoforms generated by differential splicing. Genomics 41(2):263-266 (Pubitemid 27175356)
12. Kishino T,Wagstaff J (1998) Genomic organization of the UBE3A/ E6-AP gene and related pseudogenes. Genomics 47(1):101-107 (Pubitemid 28080086)
13. Huibregtse JM, Scheffner M, Howley PM (1993) Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins.Mol Cell Biol 13(8):4918-4927 (Pubitemid 23220397)
14. Nawaz Z, Lonard DM, Smith CL, Lev-Lehman E, Tsai SY, Tsai MJ, O'Malley BW (1999) The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol 19(2):1182-1189 (Pubitemid 29046860)
15. Huibregtse JM, Scheffner M, Beaudenon S, Howley PM (1995) A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc Natl Acad Sci U S A 92(11):2563-2567
16. ScheffnerM, Huibregtse JM, Howley PM(1994) Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc Natl Acad Sci U S A 91(19):8797-8801
17. Kumar S, KaoWH, Howley PM (1997) Physical interaction between specific E2 and Hect E3 enzymes determines functional cooperativity. J Biol Chem 272(21):13548-13554 (Pubitemid 27224784)
18. Huang L, Kinnucan E, Wang G, Beaudenon S, Howley PM, Huibregtse JM, Pavletich NP (1999) Structure of an E6AP- UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. Science 286(5443):1321-1326
19. Zanier K, Charbonnier S, Baltzinger M, Nomine Y, Altschuh D, Trave G (2005) Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance. J Mol Biol 349(2):401-412 (Pubitemid 40693758)
20. Kishino T, LalandeM,Wagstaff J (1997) UBE3A/E6-APmutations cause Angelman syndrome. Nat Genet 15(1):70-73
21. Talis AL, Huibregtse JM, Howley PM (1998) The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J Biol Chem 273(11): 6439-6445 (Pubitemid 28144738)
22. Cooper B, Schneider S, Bohl J, Jiang Y, Beaudet A, Vande Pol S (2003) Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53. Virology 306(1): 87-99 (Pubitemid 36293399)
23. Dhananjayan SC, Ramamoorthy S, Khan OY, Ismail A, Sun J, Slingerland J, O'Malley BW, Nawaz Z (2006)WWdomain binding protein-2, an E6-associated protein interacting protein, acts as a coactivator of estrogen and progesterone receptors. Mol Endocrinol 20(10):2343-2354 (Pubitemid 44496405)
24. Khan OY, Fu G, Ismail A, Srinivasan S, Cao X, Tu Y, Lu S, Nawaz Z (2006) Multifunction steroid receptor coactivator, E6-associated protein, is involved in development of the prostate gland. Mol Endocrinol 20(3):544-559 (Pubitemid 43291207)
25. Salvat C,Wang G, Dastur A, Lyon N, Huibregtse JM(2004) The -4 phenylalanine is required for substrate ubiquitination catalyzed by HECT ubiquitin ligases. J Biol Chem 279(18):18935-18943 (Pubitemid 38623322)
26. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R, Benchimol S (2003) Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112(6): 779-791 (Pubitemid 36378882)
27. Li M, Brooks CL, Wu-Baer F, Chen D, Baer R, Gu W (2003) Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302(5652):1972-1975 (Pubitemid 37523506)
28. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM (2004) The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429(6987):86-92 (Pubitemid 38620556)
29. Oda H, Kumar S, Howley PM (1999) Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination. Proc Natl Acad Sci U S A 96(17):9557-9562 (Pubitemid 29398769)
30. Liu X, Yuan H, Fu B, Disbrow GL, Apolinario T, Tomaic V, Kelley ML, Baker CC, Huibregtse J, Schlegel R (2005) The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. J Biol Chem 280(11):10807-10816 (Pubitemid 40395944)
31. Liu X, Disbrow GL, Yuan H, Tomaic V, Schlegel R (2007)Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes. J Virol 81(22):12689-12695 (Pubitemid 350085884)
32. Kumar S, Talis AL, Howley PM (1999) Identification of HHR23A as a substrate for E6-associated protein-mediated ubiquitination. J Biol Chem 274(26):18785-18792
33. Nuber U, Schwarz SE, Scheffner M (1998) The ubiquitin-protein ligase E6-associated protein (E6-AP) serves as its own substrate. Eur J Biochem 254(3):643-649 (Pubitemid 28308117)
34. Kao WH, Beaudenon SL, Talis AL, Huibregtse JM, Howley PM (2000) Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase. J Virol 74(14):6408-6417 (Pubitemid 30429807)
35. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J, Gannon F (2003) Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11(3):695-707 (Pubitemid 36385123)
36. James MA, Lee JH, Klingelhutz AJ (2006) HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300. Int J Cancer 119(8): 1878-1885 (Pubitemid 44356846)
37. Catoe HW, Nawaz Z (2011) E6-AP facilitates efficient transcription at estrogen responsive promoters through recruitment of chromatin modifiers. Steroids 76(9):897-902
38. Ismail A, Nawaz Z (2005) Nuclear hormone receptor degradation and gene transcription: an update. IUBMB Life 57(7):483-490 (Pubitemid 41112986)
39. Alarid ET (2006) Lives and times of nuclear receptors. Mol Endocrinol 20(9):1972-1981
40. Nawaz Z, LonardDM, Dennis AP, Smith CL, O'Malley BW (1999) Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci U S A 96(5):1858-1862 (Pubitemid 29117832)
41. Lonard DM, Nawaz Z, Smith CL, O'Malley BW (2000) The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol Cell 5(6):939-948
42. Gao X, Mohsin SK, Gatalica Z, Fu G, Sharma P, Nawaz Z (2005) Decreased expression of E6-associated protein in breast and prostate carcinomas. Endocrinology 146(4):1707-1712 (Pubitemid 40396878)
43. Mani A, Oh AS, Bowden ET, Lahusen T, Lorick KL,Weissman AM, Schlegel R,Wellstein A, Riegel AT (2006) E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells. Cancer Res 66(17):8680-8686 (Pubitemid 44449184)
44. Rochette-Egly C (2005) Dynamic combinatorial networks in nuclear receptor-mediated transcription. J Biol Chem 280(38):32565-32568
45. Albrecht U, Sutcliffe JS, Cattanach BM, Beechey CV, Armstrong D, Eichele G, Beaudet AL (1997) Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat Genet 17(1):75-78 (Pubitemid 27377535)
46. Meng L, Person RE, Beaudet AL (2012) Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a. Hum Mol Genet 21(13):3001-3012
47. Daily J, Smith AG, Weeber EJ (2012) Spatial and temporal silencing of the human maternal UBE3A gene. Eur J Paediatr Neurol 16(6):587-591
48. Jiang YH, Armstrong D, Albrecht U, Atkins CM, Noebels JL, Eichele G, Sweatt JD, Beaudet AL (1998) Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21(4):799-811 (Pubitemid 28498788)
49. Mishra A, Jana NR (2008) Regulation of turnover of tumor suppressor p53 and cell growth by E6-AP, a ubiquitin protein ligase mutated in Angelman mental retardation syndrome. Cell Mol Life Sci 65(4):656-666
50. Mishra A, Godavarthi SK, Jana NR (2009) UBE3A/E6-AP regulates cell proliferation by promoting proteasomal degradation of p27. Neurobiol Dis 36(1):26-34
51. Greer PL, Hanayama R, Bloodgood BL,Mardinly AR, Lipton DM, Flavell SW, Kim TK, Griffith EC,Waldon Z, Maehr R, Ploegh HL, Chowdhury S, Worley PF, Steen J, Greenberg ME (2010) The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 140(5):704-716
52. Margolis SS, Salogiannis J, Lipton DM, Mandel-Brehm C, Wills ZP, Mardinly AR, Hu L, Greer PL, Bikoff JB, Ho HY, Soskis MJ, Sahin M, Greenberg ME (2010) EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation. Cell 143(3):442-455
53. Reiter LT, Seagroves TN, Bowers M, Bier E (2006) Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase. Hum Mol Genet 15(18):2825-2835 (Pubitemid 44400409)
54. Mishra A, Dikshit P, Purkayastha S, Sharma J, Nukina N, Jana NR (2008) E6-AP promotes misfolded polyglutamine proteins for proteasomal degradation and suppresses polyglutamine protein aggregation and toxicity. J Biol Chem 283(12):7648-7656
55. Mulherkar SA, Sharma J, Jana NR (2009) The ubiquitin ligase E6- AP promotes degradation of alpha-synuclein. J Neurochem 110(6): 1955-1964
56. Mishra A, Godavarthi SK, Maheshwari M, Goswami A, Jana NR (2009) The ubiquitin ligase E6-AP is induced and recruited to aggresomes in response to proteasome inhibition and may be involved in the ubiquitination of Hsp70-bound misfolded proteins. J Biol Chem 284(16):10537-10545
57. Takiyama Y (2007) Sacsinopathies: sacsin-related ataxia. Cerebellum 6(4):353-359
58. Smith CL, DeVera DG, Lamb DJ, Nawaz Z, Jiang YH, Beaudet AL, O'Malley BW (2002) Genetic ablation of the steroid receptor coactivator-ubiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction. Mol Cell Biol 22(2): 525-535 (Pubitemid 34027497)
59. Nishihara E, O'Malley BW, Xu JM (2004) Nuclear receptor coregulators are new players in nervous system development and function. Mol Neurobiol 30(3):307-325 (Pubitemid 41264552)
60. Ferdousy F, Bodeen W, Summers K, Doherty O,Wright O, Elsisi N, Hilliard G, O'Donnell JM, Reiter LT (2011) Drosophila Ube3a regulates monoamine synthesis by increasing GTP cyclohydrolase I activity via a non-ubiquitin ligase mechanism. Neurobiol Dis 41(3): 669-677
61. Godavarthi SK, Dey P, Maheshwari M, Jana NR (2012) Defective glucocorticoid hormone receptor signaling leads to increased stress and anxiety in a mouse model of Angelman syndrome. Hum Mol Genet 21(8):1824-1834
62. Low D, Chen KS (2010) Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation. Eur J Hum Genet 18(11):1228-1235
63. Wu Y, Bolduc FV, Bell K, Tully T, Fang Y, Sehgal A, Fischer JA (2008) A Drosophila model for Angelman syndrome. Proc Natl Acad Sci U S A 105(34):12399-12404
64. Lu Y, Wang F, Li Y, Ferris J, Lee JA, Gao FB (2009) The Drosophila homologue of the Angelman syndrome ubiquitin ligase regulates the formation of terminal dendritic branches. Hum Mol Genet 18(3):454-462
65. Dindot SV, Antalffy BA, Bhattacharjee MB, Beaudet AL (2008) The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum Mol Genet 17(1):111-118
66. Yashiro K, Riday TT, Condon KH, Roberts AC, Bernardo DR, Prakash R, Weinberg RJ, Ehlers MD, Philpot BD (2009) Ube3a is required for experience-dependent maturation of the neocortex. Nat Neurosci 12(6):777-783
67. Jiang YH, Pan Y, Zhu L, Landa L, Yoo J, Spencer C, Lorenzo I, Brilliant M, Noebels J, Beaudet AL (2010) Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3. PLoS One 5(8):e12278
68. Condon KH, Ho J, Robinson CG, Hanus C, Ehlers MD (2013) The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation. J Neurosci 33(9):3799- 3814
69. Gustin RM, Bichell TJ, Bubser M, Daily J, Filonova I, Mrelashvili D, Deutch AY, Colbran RJ, Weeber EJ, Haas KF (2010) Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome. Neurobiol Dis 39(3):283-291
70. Heck DH, Zhao Y, Roy S, LeDoux MS, Reiter LT (2008) Analysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors. Hum Mol Genet 17(14):2181-2189 (Pubitemid 351911986)
71. Lossie AC,WhitneyMM, Amidon D, Dong HJ, Chen P, Theriaque D, Hutson A, Nicholls RD, Zori RT, Williams CA, Driscoll DJ (2001) Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet 38(12):834-845 (Pubitemid 34014208)
72. Varela MC, Kok F, Otto PA, Koiffmann CP (2004) Phenotypic variability in Angelman syndrome: comparison among different deletion classes and between deletion and UPD subjects. Eur J Hum Genet 12(12):987-992 (Pubitemid 39600125)
73. Dan B, Cheron G (2004) Postural rhythmic muscle bursting activity in Angelman syndrome. Brain Dev 26(6):389-393 (Pubitemid 38953327)
74. Cheron G, Servais L, Dan B, Gall D, Roussel C, Schiffmann SN (2005) Fast oscillation in the cerebellar cortex of calcium binding protein-deficient mice: a new sensorimotor arrest rhythm. Prog Brain Res 148:165-180
75. Mulherkar SA, Jana NR (2010) Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome. Neurobiol Dis 40(3):586-592
76. Harbord M (2001) Levodopa responsive Parkinsonism in adults with Angelman syndrome. J Clin Neurosci 8(5):421-422
77. Sato M, Stryker MP (2010) Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a. Proc Natl Acad Sci U S A 107(12):5611-5616
78. Dorrn AL, Yuan K, Barker AJ, Schreiner CE, Froemke RC (2010) Developmental sensory experience balances cortical excitation and inhibition. Nature 465(7300):932-936
79. Weeber EJ, Jiang YH, Elgersma Y, Varga AW, Carrasquillo Y, Brown SE, Christian JM, Mirnikjoo B, Silva A, Beaudet AL, Sweatt JD (2003) Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome. J Neurosci 23(7):2634-2644
80. van Woerden GM, Harris KD, Hojjati MR, Gustin RM, Qiu S, de Avila Freire R, Jiang YH, Elgersma Y,Weeber EJ (2007) Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alphaCaMKII inhibitory phosphorylation. Nat Neurosci 10(3):280-282
81. Jay V, Becker LE, Chan FW, Perry TL Sr (1991) Puppet-like syndrome of Angelman: a pathologic and neurochemical study. Neurology 41(3):416-422
82. Cao C, Rioult-Pedotti MS, Migani P, Yu CJ, Tiwari R, Parang K, SpallerMR, Goebel DJ,Marshall J (2013) Impairment of TrkB-PSD- 95 signaling in Angelman syndrome. PLoS Biol 11(2):e1001478
83. Engert JC, Berube P, Mercier J, Dore C, Lepage P, Ge B, Bouchard JP, Mathieu J, Melancon SB, Schalling M, Lander ES, Morgan K, Hudson TJ, Richter A (2000) ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF. Nat Genet 24(2):120-125 (Pubitemid 30094710)
84. Parfitt DA,Michael GJ, Vermeulen EG, Prodromou NV,Webb TR, Gallo JM, Cheetham ME, Nicoll WS, Blatch GL, Chapple JP (2009) The ataxia protein sacsin is a functional co-chaperone that protects against polyglutamine-expanded ataxin-1. HumMol Genet 18(9):1556-1565
85. Ramamoorthy S, Nawaz Z (2008) E6-associated protein (E6-AP) is a dual function coactivator of steroid hormone receptors. Nucl Recept Signal 6:e006
86. Miura K, Kishino T, Li E,Webber H, Dikkes P, Holmes GL, Wagstaff J (2002) Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice. Neurobiol Dis 9(2): 149-159 (Pubitemid 34261211)
87. Clayton-Smith J, Laan L (2003) Angelman syndrome: a review of the clinical and genetic aspects. J Med Genet 40(2):87-95 (Pubitemid 36232812)
88. Pelc K, Cheron G, Boyd SG, Dan B (2008) Are there distinctive sleep problems in Angelman syndrome? Sleep Med 9(4):434-441 (Pubitemid 351664084)
89. Yamasaki K, Joh K, Ohta T, Masuzaki H, Ishimaru T, Mukai T, Niikawa N, Ogawa M, Wagstaff J, Kishino T (2003) Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. Hum Mol Genet 12(8):837-847 (Pubitemid 36504026)
90. Mardirossian S, Rampon C, Salvert D, Fort P, Sarda N (2009) Impaired hippocampal plasticity and altered neurogenesis in adult Ube3a maternal deficient mouse model for Angelman syndrome. Exp Neurol 220(2):341-348
91. Smith SE, Zhou YD, Zhang G, Jin Z, Stoppel DC, Anderson MP (2011) Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. Sci Transl Med 3(103):103ra97
92. Williams CA (2005) Neurological aspects of the Angelman syndrome. Brain Dev 27(2):88-94
93. Lalande M, Calciano MA (2007) Molecular epigenetics of Angelman syndrome. Cell Mol Life Sci 64(7-8):947-960 (Pubitemid 46597759)
94. Matsuura T, Sutcliffe JS, Fang P, Galjaard RJ, Jiang YH, Benton CS, Rommens JM, Beaudet AL (1997) De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet 15(1):74-77 (Pubitemid 27014953)
95. Sutcliffe JS, Jiang YH, Galijaard RJ,Matsuura T, Fang P, Kubota T, Christian SL, Bressler J, Cattanach B, Ledbetter DH, Beaudet AL (1997) The E6-Ap ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region. Genome Res 7(4):368-377 (Pubitemid 27183005)
96. Amir RE, Van den Veyver IB,WanM, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23(2):185-188 (Pubitemid 29455390)
97. Matijevic T, Knezevic J, Slavica M, Pavelic J (2009) Rett syndrome: from the gene to the disease. Eur Neurol 61(1):3-10
98. Samaco RC, Hogart A, LaSalle JM (2005) Epigenetic overlap in autism-spectrumneurodevelopmental disorders:MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet 14(4):483-492 (Pubitemid 40277464)
99. Moretti P, Zoghbi HY (2006) MeCP2 dysfunction in Rett syndrome and related disorders. Curr Opin Genet Dev 16(3):276-281 (Pubitemid 43732423)
100. Makedonski K, Abuhatzira L, Kaufman Y, Razin A, Shemer R (2005) MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum Mol Genet 14(8):1049-1058 (Pubitemid 40575880)
101. Jordan C, Francke U (2006) Ube3a expression is not altered in Mecp2 mutant mice. Hum Mol Genet 15(14):2210-2215 (Pubitemid 43985512)
102. Jiang Y, Tsai TF, Bressler J, Beaudet AL (1998) Imprinting in Angelman and Prader-Willi syndromes. Curr Opin Genet Dev 8(3):334-342 (Pubitemid 28340086)
103. Mann MR, Bartolomei MS (1999) Towards a molecular understanding of Prader-Willi and Angelman syndromes. Hum Mol Genet 8(10):1867-1873 (Pubitemid 29458664)
104. Peters SU, Beaudet AL, Madduri N, Bacino CA (2004) Autism in Angelman syndrome: implications for autism research. Clin Genet 66(6):530-536 (Pubitemid 39562016)
105. Veltman MW, Craig EE, Bolton PF (2005) Autism spectrum disorders in Prader-Willi and Angelman syndromes: a systematic review. Psychiatr Genet 15(4):243-254 (Pubitemid 44491462)
106. Hughes JR (2009) Update on autism: a review of 1300 reports published in 2008. Epilepsy Behav 16(4):569-589
107. O'Hare A (2009) Autism spectrum disorder: diagnosis and management. Arch Dis Child Educ Pract Ed 94(6):161-168
108. Verhoeven JS, De Cock P, Lagae L, Sunaert S (2010) Neuroimaging of autism. Neuroradiology 52(1):3-14
109. Cook EH Jr, Lindgren V, Leventhal BL, Courchesne R, Lincoln A, Shulman C, Lord C, Courchesne E (1997) Autismor atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet 60(4):928-934 (Pubitemid 27146502)
110. Sutcliffe JS, Nurmi EL, Lombroso PJ (2003) Genetics of childhood disorders: XLVII. Autism: Part 6. Duplication and inherited susceptibility of chromosome 15q11-q13 genes in autism. J Am Acad Child Adolesc Psychiatry 42(2):253-256
111. Glessner JT,Wang K, Cai G, Korvatska O, KimCE,Wood S, Zhang H, Estes A, Brune CW, Bradfield JP, Imielinski M, Frackelton EC, Reichert J, Crawford EL, Munson J, Sleiman PM, Chiavacci R, Annaiah K, Thomas K, Hou C, Glaberson W, Flory J, Otieno F, Garris M, Soorya L, Klei L, Piven J, Meyer KJ, Anagnostou E, Sakurai T, Game RM, Rudd DS, Zurawiecki D, McDougle CJ, Davis LK, Miller J, Posey DJ, Michaels S, Kolevzon A, Silverman JM, Bernier R, Levy SE, Schultz RT, Dawson G, Owley T, McMahon WM, Wassink TH, Sweeney JA, Nurnberger JI, Coon H, Sutcliffe JS, Minshew NJ, Grant SF, Bucan M, Cook EH, Buxbaum JD, Devlin B, Schellenberg GD, Hakonarson H (2009) Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459(7246): 569-573
112. Shimura H, Schlossmacher MG, Hattori N, Frosch MP, Trockenbacher A, Schneider R, Mizuno Y, Kosik KS, Selkoe DJ (2001) Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 293(5528):263-269 (Pubitemid 32694735)
113. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science 302(5646):841 (Pubitemid 37339619)
114. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable onHuntington's disease chromosomes. Cell 72(6):971-983
115. Orr HT, Zoghbi HY (2007) Trinucleotide repeat disorders. Annu Rev Neurosci 30:575-621 (Pubitemid 47218768)
116. Landles C, Bates GP (2004) Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. EMBO Rep 5(10):958-963 (Pubitemid 39534452)
117. MaheshwariM, Samanta A, Godavarthi SK,Mukherjee R, Jana NR (2012) Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease. J Biol Chem 287(35):29949-29957